Cancer News and Research

Latest Cancer News and Research

UCSD Moores Cancer Center expert available to discuss breast brachytherapy

Recent controversy about breast brachytherapy - a shorter course of radiation treatment for breast cancer - has called into question whether the technique is being offered to too many women. New research on an advanced form of brachytherapy is now being reported by UC San Diego Moores Cancer Center and 11 other centers in the United States. These studies report highly favorable outcomes for a form of breast brachytherapy called SAVI.

11 Apr 2012

QRxPharma completes MoxDuo CR Phase 1 studies on chronic pain

QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.

11 Apr 2012

Rate of childhood obesity triples in 30 years

Nearly 18 percent of U.S. school-aged children and adolescents are obese, as the rate of childhood obesity has more than tripled in the past 30 years. The prevalence of obesity puts children at greater risk of developing heart disease, type 2 diabetes, stroke and other illnesses, and of suffering severe obesity as adults.

11 Apr 2012

Amgen enters agreement to acquire KAI Pharmaceuticals

Amgen and KAI Pharmaceuticals today announced an agreement under which Amgen will acquire KAI, a privately held pharmaceutical company based in South San Francisco.

11 Apr 2012

Peter Mac doctor receives grant to fight prostate cancer

The Victorian Minister for Health, the Hon David Davis, with the Richard Pratt Fellowships in Prostate Cancer Foundation and the Carlton Football Club, today announced Dr Helen Pearson as the 2012 recipient of the Richard Pratt Fellowship in Prostate Cancer Research.

10 Apr 2012

Spider venom studied as treatment for breast cancer

James Cook University Professor Norelle Daly has received a $205,000 research grant from the National Breast Cancer Foundation to analyze whether the venom of tarantulas and funnel web spiders can kill breast cancer cells.

10 Apr 2012

Soon a vaccine that targets 90% of all cancers

Results from the safety trial - on patients with blood cancer - found all had greater immunity to the disease after receiving the vaccine. Three of the seven patients who have completed the treatment are now free of the condition.

10 Apr 2012

High cancer treatment costs in the US – are they worth it? Study explores

Healthcare in the United States is costlier than care in other countries. A new analysis suggests that the cost may be worth it at least when it comes to cancer care. Americans may pay more for cancer treatment, but they also live longer after diagnosis — getting a benefit that offsets their higher health expenses the study says.

10 Apr 2012

First Edition: April 10, 2012

In today's headlines, a new study finds that the health law, which has long been touted as a means to control costs, could add more than $340 billion to the nation's budget difficulties in the next ten years.

10 Apr 2012

Biovest seeks Health Canada approval of BiovaxID for follicular NHL

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest is seeking marketing approval in Canada for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.

10 Apr 2012

Delcath, NKI-AVL enter initial launch and training agreement for CHEMOSAT system

Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement with the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands.

10 Apr 2012

Provectus announces data from PV-10 Phase 2 study on metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 study of PV-10 for metastatic melanoma will be presented at the HemOnc Today - Melanoma and Cutaneous Malignancies Conference on April 13, 2012.

10 Apr 2012

Lee's Pharma licenses rights to commercialize PL2200 Aspirin in China

PLx Pharma Inc, a Houston based pharmaceutical company developing gastrointestinal (GI) safer drugs has licensed to Lee's Pharmaceutical Holdings Limited (Lee's Pharma) the rights to register and commercialize in China, Hong Kong and Macau the PL2200 Aspirin, a GI safer aspirin product currently in development in the US, for prevention of cardiovascular diseases. Cardiovascular is one of the focus areas of Lee's Pharma.

10 Apr 2012

Canon, MEDIAN to demonstrate LMS clinical application portfolio at ITEM

MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, announced today it will demonstrate its Lesion Management Solutions -LMS- clinical application portfolio together with Canon at ITEM, April 13-15, 2012 in Yokohama, Japan.

10 Apr 2012

Low-dose spiral CT cost-effective in reducing lung cancer deaths

Lung cancer is the most lethal cancer in the United States. According to the National Cancer Institute, lung cancer causes more than 150,000 deaths annually and has a survival rate of 16 percent. More Americans die of lung cancer each year than of cervical, breast, colon and prostate cancers combined.

10 Apr 2012

First study to examine long-term effects of climate change on life expectancy

New research from Harvard School of Public Health (HSPH) suggests that seemingly small changes in summer temperature swings-as little as 1-C more than usual-may shorten life expectancy for elderly people with chronic medical conditions, and could result in thousands of additional deaths each year.

10 Apr 2012

Potential role of aspirin in reducing risk of cancer death

A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care.

10 Apr 2012

UCSD surgeon implants new INX device in a 29-year old patient with GERD

On Monday, April 9, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease (GERD), a chronic digestive disease that can lead to severe inflammation, stricture, Barrett's esophagus and esophageal cancer.

10 Apr 2012

FDA Advisory Panel to review somo•v Automated Breast Ultrasound System

Women with dense breast tissue are a step closer to having access to an important new breast cancer screening tool.

10 Apr 2012

Large proportion of obese Americans can and do lose weight, say researchers

Contrary to popular perception, a large proportion of obese Americans can and do lose weight, say researchers at Beth Israel Deaconess Medical Center. What's more, they say, the old tried and true methods of eating less fat and exercising are some of the most effective paths to weight loss success.

10 Apr 2012